# Yerem Yeghiazarians

> Yerem Yeghiazarians is the co-founder and CEO of Soley Therapeutics, which he founded with Kurosh Ameri in 2020 after years of collaboration at UCSF. A Brandeis and Johns Hopkins graduate who joined UCSF in 2003, he has authored more than 110 peer-reviewed papers and edited two books. His public accounts emphasize his immigrant beginnings, mentorship and the importance of assembling a team with complementary experience.

- **Role:** Co-founder and Chief Executive Officer at Soley Therapeutics
- **Organizations:** Soley Therapeutics, University of California, San Francisco, Brigham and Women’s Hospital, American Heart Association, San Francisco Bay Area
- **Education:** B.A. in biology and biochemistry, Brandeis University, M.D., Johns Hopkins University School of Medicine, Postgraduate training, including residency, chief residency and fellowships, Brigham and Women’s Hospital, Harvard Medical School
- **Known for:** Co-founded Soley Therapeutics in 2020., Published more than 110 peer-reviewed papers and edited two books, according to his company biography., Served as chief resident and instructor at Brigham and Women’s Hospital.

## Career timeline

- **1991** — Graduated from Brandeis University.
- **1995** — Earned his M.D. at Johns Hopkins.
- **2003** — Joined UCSF.
- **2010** — Began the collaboration with Kurosh Ameri dated in Soley’s company history.
- **2020** — Co-founded Soley Therapeutics with Kurosh Ameri.
- **2025** — Oracle publicly announced a collaboration with Soley in March.
- **2026** — Soley announced a $200 million Series C on January 7.

## Achievements

- Co-founded Soley Therapeutics in 2020.
- Published more than 110 peer-reviewed papers and edited two books, according to his company biography.
- Served as chief resident and instructor at Brigham and Women’s Hospital.
- Built and led an academic research program at UCSF.

## Latest updates

- **2026-10** — Soley’s news page listed its inclusion in Fierce Biotech’s 2026 Fierce 15 on October 5.
- **2026-03** — Appeared on Episode 135 of The BioHub podcast, published March 25.
- **2026-02** — Discussed hiring, team building and founder responsibilities in a February 11 interview.
- **2026-01** — Soley announced a $200 million Series C financing on January 7.

## Links

- Website: https://soleytherapeutics.com/team-member/yerem-yeghiazarians-m-d/
- LinkedIn: https://www.linkedin.com/in/yerem-yeghiazarians-4b561b1a/

---

Profile page: https://yespress.io/yerem-yeghiazarians
Published by YesPress — https://yespress.io
Last updated: 2026-10-25